EyePoint Pharmaceuticals (EYPT) Prices 15M Share Common Offering at $1.45/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
After-Hours Stock Movers 02/20: (ZIXI) (EHTH) (DBX) Higher (EYPT) (TRUE) (FSLR) Lower (more...)
February 20, 2020 5:42 PM ESTAfter-Hours Stock Movers
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) 18.5% LOWER; announced that it intends to offer and sell shares of its common stock in an underwritten public offering.
TrueCar (NASDAQ: TRUE) 18.2% LOWER; reported Q4 EPS of ($0.01), $0.03 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $89.7 million versus the consensus estimate of $88.05 million. TrueCar sees Q1 2020 revenue of $87-89 million, versus the consensus of $86.92 million. TrueCar sees FY2020 revenue of $335-355 million, versus the consensus of... More
EyePoint Pharmaceuticals (EYPT) to Offer Common Stock
February 20, 2020 4:22 PM ESTEyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering will be offered by EyePoint. The offering is subject... More
